左旋多巴应何时开始使用？ - Suppr

Suppr

超能文献

When should levodopa be started?

作者信息

Quinn N, Critchley P, Parkes D, Marsden C D

出版信息

Lancet. 1986 Oct 25;2(8513):985-6. doi: 10.1016/s0140-6736(86)90642-2.

DOI:10.1016/s0140-6736(86)90642-2

PMID:2877169

Abstract

摘要

相似文献

When should levodopa be started?

Lancet. 1986 Oct 25;2(8513):985-6. doi: 10.1016/s0140-6736(86)90642-2.

What to do when Sinemet fails: Part one.

Clin Neuropharmacol. 1984;7(2):121-33.

Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease.

Mov Disord. 1991;6(1):91-2. doi: 10.1002/mds.870060122.

Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.

Mov Disord. 1993 Apr;8(2):139-43. doi: 10.1002/mds.870080204.

[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].

Ned Tijdschr Geneeskd. 1982 Apr 17;126(16):701-5.

[On and off phenomenon].

Nihon Rinsho. 1977 Spring;35 Suppl 1:618-9.

Buspirone in the treatment of levodopa induced dyskinesias.

J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):376-7. doi: 10.1136/jnnp.54.4.376-a.

Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.

Mov Disord. 1994 Mar;9(2):238-40. doi: 10.1002/mds.870090224.

[Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, HCL-benserazide, on Parkinson's disease-part I: clinical aspects (author's transl)].

No To Shinkei. 1979 Mar;31(3):295-304.

Long-term effects of home-made levodopa in 43 cases of paralysis agitans.

Chin Med J (Engl). 1979 Nov;92(11):807-10.

引用本文的文献

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004554. doi: 10.1002/14651858.CD004554.pub2.

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004553. doi: 10.1002/14651858.CD004553.pub2.

Amantadine for dyskinesia in Parkinson's disease.

Cochrane Database Syst Rev. 2003;2003(2):CD003467. doi: 10.1002/14651858.CD003467.

Amantadine in Parkinson's disease.

Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.

Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2001;2001(1):CD001519. doi: 10.1002/14651858.CD001519.

Cabergoline for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2001;2001(1):CD001518. doi: 10.1002/14651858.CD001518.

Pramipexole for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2000;2000(3):CD002261. doi: 10.1002/14651858.CD002261.

Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2000;2000(3):CD002259. doi: 10.1002/14651858.CD002259.

Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2000;2001(3):CD001517. doi: 10.1002/14651858.CD001517.

Lisuride for levodopa-induced complications in Parkinson's disease.

Cochrane Database Syst Rev. 2000;1999(2):CD001515. doi: 10.1002/14651858.CD001515.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验